1. Alzheimer's disease drug development pipeline: 2018
Jeffrey Cummings, Garam Lee, Aaron Ritter, Kate Zhong 
Alzheimer's & Dementia: Translational Research & Clinical Interventions 
Volume 4, Pages (January 2018)
DOI: /j.trci
Copyright © 2018 The Authors Terms and Conditions

2. Fig. 1
Agents in clinical trials for treatment of Alzheimer's disease in 2018 (from clinicaltrials.gov accessed January 30, 2018).
Alzheimer's & Dementia: Translational Research & Clinical Interventions 2018 4, DOI: ( /j.trci )
Copyright © 2018 The Authors Terms and Conditions

3. Fig. 2 Mechanisms of action of agents in phase III.
Alzheimer's & Dementia: Translational Research & Clinical Interventions 2018 4, DOI: ( /j.trci )
Copyright © 2018 The Authors Terms and Conditions

4. Fig. 3 Mechanisms of action of agents in phase II.
Alzheimer's & Dementia: Translational Research & Clinical Interventions 2018 4, DOI: ( /j.trci )
Copyright © 2018 The Authors Terms and Conditions

5. Fig. 4 Site of action of anti-tau agents.
Alzheimer's & Dementia: Translational Research & Clinical Interventions 2018 4, DOI: ( /j.trci )
Copyright © 2018 The Authors Terms and Conditions